Literature DB >> 283689

A family with acute leukemia, hypoplastic anemia and cerebellar ataxia: association with bone marrow C-monosomy.

F P Li, N U Potter, G R Buchanan, G Vawter, J Whang-Peng, R B Rosen.   

Abstract

The eldest brother in a sibship of five children died of acute myelogenous leukemia at 10 years of age. The second and third eldest brothers died of hypoplastic anemia at ages five and nine years, respectively. A surviving 6 year old brother, the proband of the study, has abnormalities that suggest a preleukemic state: mild pancytopenia, platelet dysfunction, immunodeficiency, and bone marrow hypoplasia with approximately 18 per cent blast forms. His 17 year old sister has a mild normochromic normocytic anemia. Cytogenetic studies revealed C-group monosomy in the bone marrows of the proband and the third brother (45, XY, -C); band studies demonstrated that a No. 8 chromosome was missing in the proband (45, XY, -8). At least four of the siblings and their father had cerebellar ataxia, and evidence of a small cerebellum at autopsy examination or by computerized axial tomography. The disorder in this family has major features of two autosomal recessive preleukemic diseases, ataxia-telangiectasia and Fanconi's anemia. However, these and other inherited conditions were excluded by clinical or laboratory criteria, and no environmental causes of the familial disorder were found. The constellation of abnormalities in the family may constitute a new genetic syndrome.

Entities:  

Mesh:

Year:  1978        PMID: 283689     DOI: 10.1016/0002-9343(78)90744-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

1.  Familial leukemia: Ph1 positive acute lymphoid leukemia of a mother and her infant.

Authors:  E Oláh; V Stenszky; A Kiss; I Kovács; E Balogh; L Karmazsin
Journal:  Blut       Date:  1981-10

2.  Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms.

Authors:  Bianca Tesi; Josef Davidsson; Matthias Voss; Elisa Rahikkala; Tim D Holmes; Samuel C C Chiang; Jonna Komulainen-Ebrahim; Sorina Gorcenco; Alexandra Rundberg Nilsson; Tim Ripperger; Hannaleena Kokkonen; David Bryder; Thoas Fioretos; Jan-Inge Henter; Merja Möttönen; Riitta Niinimäki; Lars Nilsson; Cornelis Jan Pronk; Andreas Puschmann; Hong Qian; Johanna Uusimaa; Jukka Moilanen; Ulf Tedgård; Jörg Cammenga; Yenan T Bryceson
Journal:  Blood       Date:  2017-02-15       Impact factor: 22.113

3.  Ataxia telangiectasia with generalized skin pigmentation and early death.

Authors:  M Tsukahara; M Masuda; K Ohshiro; K Kobayashi; T Kajii; Y Ejima; M S Sasaki
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

4.  Ataxia-Pancytopenia Syndrome Is Caused by Missense Mutations in SAMD9L.

Authors:  Dong-Hui Chen; Jennifer E Below; Akiko Shimamura; Sioban B Keel; Mark Matsushita; John Wolff; Youngmee Sul; Emily Bonkowski; Maria Castella; Toshiyasu Taniguchi; Deborah Nickerson; Thalia Papayannopoulou; Thomas D Bird; Wendy H Raskind
Journal:  Am J Hum Genet       Date:  2016-06-02       Impact factor: 11.025

Review 5.  SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies.

Authors:  Josef Davidsson; Andreas Puschmann; Ulf Tedgård; David Bryder; Lars Nilsson; Jörg Cammenga
Journal:  Leukemia       Date:  2018-02-25       Impact factor: 11.528

6.  Ataxia-pancytopenia syndrome with SAMD9L mutations.

Authors:  Sorina Gorcenco; Jonna Komulainen-Ebrahim; Karin Nordborg; Maria Suo-Palosaari; Sten Andréasson; Johanna Krüger; Christer Nilsson; Ulrika Kjellström; Elisa Rahikkala; Dominik Turkiewicz; Mikael Karlberg; Lars Nilsson; Jörg Cammenga; Ulf Tedgård; Josef Davidsson; Johanna Uusimaa; Andreas Puschmann
Journal:  Neurol Genet       Date:  2017-08-24

7.  Leukoencephalopathia, demyelinating peripheral neuropathy and dural ectasia explained by a not formerly described de novo mutation in the SAMD9L gene, ends 27 years of investigations - a case report.

Authors:  Sofia Thunström; Markus Axelsson
Journal:  BMC Neurol       Date:  2019-05-03       Impact factor: 2.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.